This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
In the Matter of Bodisen Biotech, Inc., China Global Media, Inc., China Heli Resource Renewable, Inc., and GFR Pharmaceuticals, Inc.; Order of Suspension of Trading
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
There is no table of contents available for this document.
Related Documents
Enhanced Content - Related Documents
FederalRegister.gov uses the agency dockets published with the document to display related documents.
In the Matter of Bodisen Biotech, Inc., China Global Media, Inc., China Heli Resource Renewable, Inc., and GFR Pharmaceuticals, Inc.; Order of Suspension of Trading
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
65
as of
09/11/2026 at 4:15 pm EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2016-12288 as it appeared on Public Inspection on
05/20/2016 at 11:15 am.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2016-12288 (81 FR 32820)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Bodisen Biotech, Inc. (CIK No. 1178552), a forfeited Delaware corporation with its principal place of business listed as Shaanxi, China with stock quoted on OTC Link (previously, “Pink Sheets”) operated by OTC Markets Group, Inc. (“OTC Link”) under the ticker symbol BBCZ, because it has not filed any periodic reports since the period ended June 30, 2013. On August 18, 2015, a delinquency letter was sent by the Division of Corporation Finance to Bodisen Biotech, Inc. requesting compliance with its periodic filing obligations, but Bodisen Biotech, Inc. refused to accept delivery of the delinquency letter.
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of China Global Media, Inc. (CIK No. 1450015), a revoked Nevada corporation with its principal place of business listed as Hunan Province, China with stock quoted on OTC Link under the ticker symbol CGLO, because it has not filed any periodic reports since the period ended June 30, 2013. On August 18, 2015, a delinquency letter was sent by the Division of Corporation Finance to China Global Media, Inc. requesting compliance with its periodic filing obligations, and China Global Media, Inc. did not receive the delinquency letter due to its failure to maintain a valid address on file with the Commission as required by Commission rules (Rule 301 of Regulation S-T, 17 CFR 232.301 and Section 5.4 of EDGAR Filer Manual).
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of China Heli Resource Renewable, Inc. (CIK No. 1081823), a British Virgin Islands corporation with its principal place of business listed as Xin Jiang Province, China with stock quoted on OTC Link under the ticker symbol CRRWF, because it has not filed any periodic reports since the period ended
( printed page 32821)
December 31, 2012. On August 18, 2015, a delinquency letter was sent by the Division of Corporation Finance to China Heli Resource Renewable, Inc. requesting compliance with its periodic filing obligations, but China Heli Resource Renewable, Inc. did not receive the delinquency letter due to its failure to maintain a valid address on file with the Commission as required by Commission rules (Rule 301 of Regulation S-T, 17 CFR 232.301 and Section 5.4 of EDGAR Filer Manual).
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of GFR Pharmaceuticals, Inc. (CIK No. 1096294), a Nevada corporation with its principal place of business listed as Shaanxi Province, China with stock quoted on OTC Link under the ticker symbol GFRP, because it has not filed any periodic reports since the period ended March 31, 2013. On November 3, 2015, a delinquency letter was sent by the Division of Corporation Finance to GFR Pharmaceuticals, Inc. requesting compliance with its periodic filing obligations, and GFR Pharmaceuticals, Inc. received the delinquency letter on November 9, 2015, but failed to cure its delinquencies.
The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies.
Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed companies is suspended for the period from 9:30 a.m. EDT on May 20, 2016, through 11:59 p.m. EDT on June 3, 2016.